Society of You review

The range of injectable choices may interest self-pay readers. Do not treat the card amounts as monthly totals or the cancellation slogan as a refund promise: confirm the first payment, renewal interval, product and pharmacy before proceeding.

Society of You is a wellness platform operated under the Society Management Group name. Its terms separate the platform from independent medical providers and partner pharmacies. Emerald Pharmacy and Striker Pharmacy are named, but the public pages do not identify the prescribing medical-group entity or the pharmacy assigned to an individual order.

The weight-loss page lists clinicians by name and role. Those are the site's descriptions rather than independent credential checks. The presence of a clinician on another telehealth service would not by itself make the services the same business. Society also advertises other wellness treatments; their presence in navigation does not show that each item is available in every state or appropriate for a particular patient.

Society describes an online intake, independent provider review, prescription when appropriate and pharmacy shipment. The weight-loss FAQ says its current GLP-1 offering is injectable only. The platform's general terms refer to availability across all fifty states, while its consent and location language condition care on clinician licensure and product rules. An adult should confirm availability for the chosen medication and their own state.

Marketing says plans include prescription, medication, shipping and clinical support, with no long-term contract and the ability to pause or cancel anytime. Terms describe an automatically renewing subscription at the interval shown at checkout. Cancellation must occur at least 48 hours before renewal processing and takes effect at the period end. There are no partial-period refunds.

The separate refund policy says the first two months of a treatment plan are nonrefundable and an active order cannot simply be stopped. It also describes possible prescriber-ineligibility and verified-billing-error exceptions, which sit awkwardly beside the broad no-refund wording. Ask how an ineligibility decision is handled before payment and retain the written terms for the selected plan. Lab testing is advertised on a page marked coming soon; it is not an established included or bookable GLP-1 service.

Product cards list semaglutide from $149 and tirzepatide from $249, including separate low-dose variants at the same starting figures. They do not clearly state a billing period, supply duration, total upfront debit or later price. Society's terms say the subscription price may combine platform, provider and pharmacy charges, and that the actual renewal interval is presented at checkout. A card amount therefore cannot be used as a verified monthly comparison floor.

The homepage says plans include medication and shipping, but the exact prescribed product, first charge, recurring amount, strength-related price and laboratory costs are not established in the public card. The refund policy's mention of introductory pricing does not specify which offer qualifies or how long an introduction lasts. Ask for a written schedule covering the first two payments and the point at which cancellation stops future charges.

Ozempic, Wegovy and Mounjaro cards carry large starting figures but are marked coming soon. They do not establish a currently purchasable brand-drug option. The separate lab page also carries a coming-soon notice, despite publishing test prices.

Society's current weight-loss text describes weekly injectable semaglutide and tirzepatide and says it uses tailored compounded medication. Exact concentration, additives, pharmacy assignment and prescribed quantity remain individual questions. Compounded formulations are not FDA-approved equivalents of the named brands.

The product display contains conflicting medical labels: a metformin card is headed oral but also describes a weekly injection, and some GLP-1 cards show dose fields that do not align with their product names. Those fields should not be used as dosing instructions. Obtain the actual drug, route and directions from the prescriber and dispensing pharmacy. Coming-soon branded cards should not be counted among current treatment choices.